ASE·Healthcare·$185M·#223 / 520 in Healthcare
STXS Stereotaxis, Inc.
49SPECULATIVE
CATEGORY BREAKDOWN
GROWTH32
QUALITY44
STABILITY51
VALUATION66
GOVERNANCE61
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+20.3%
32
> 50% strong
Gross Margin
Revenue retained after direct costs
52.7%
74
> 50% strong
Cash Runway
Months of cash at current burn rate
12 months
39
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
29.0%
76
< 25% strong
Price / Sales
Market cap relative to trailing revenue
5.7x
66
< 3x strong
Rule of 40
Growth rate plus operating margin
-48
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
15.4%
76
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+13.4%
30
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE STXS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when STXS's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.